Lance Wilkes
Stock Analyst at Bernstein
(2.07)
# 2,904
Out of 4,944 analysts
26
Total ratings
58.33%
Success rate
2.53%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lance Wilkes
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
MOH Molina Healthcare | Initiates: Outperform | $414 | $157.31 | +163.17% | 1 | Apr 22, 2025 | |
AGL agilon health | Initiates: Market Perform | $2.5 | $0.89 | +180.43% | 1 | Dec 11, 2024 | |
CNC Centene | Maintains: Outperform | $96 → $88 | $26.17 | +236.26% | 4 | Oct 30, 2024 | |
HUM Humana | Upgrades: Outperform | $308 | $274.94 | +12.02% | 3 | Oct 8, 2024 | |
HCA HCA Healthcare | Downgrades: Market Perform | $301 | $390.31 | -22.88% | 4 | Jan 4, 2024 | |
CI The Cigna Group | Upgrades: Outperform | $372 | $280.47 | +32.63% | 6 | Jan 4, 2024 | |
UNH UnitedHealth Group | Upgrades: Outperform | $595 → $603 | $261.57 | +130.53% | 4 | Jul 18, 2023 | |
CVS CVS Health | Maintains: Market Perform | $107 → $93 | $65.51 | +41.96% | 3 | May 2, 2023 |
Molina Healthcare
Apr 22, 2025
Initiates: Outperform
Price Target: $414
Current: $157.31
Upside: +163.17%
agilon health
Dec 11, 2024
Initiates: Market Perform
Price Target: $2.5
Current: $0.89
Upside: +180.43%
Centene
Oct 30, 2024
Maintains: Outperform
Price Target: $96 → $88
Current: $26.17
Upside: +236.26%
Humana
Oct 8, 2024
Upgrades: Outperform
Price Target: $308
Current: $274.94
Upside: +12.02%
HCA Healthcare
Jan 4, 2024
Downgrades: Market Perform
Price Target: $301
Current: $390.31
Upside: -22.88%
The Cigna Group
Jan 4, 2024
Upgrades: Outperform
Price Target: $372
Current: $280.47
Upside: +32.63%
UnitedHealth Group
Jul 18, 2023
Upgrades: Outperform
Price Target: $595 → $603
Current: $261.57
Upside: +130.53%
CVS Health
May 2, 2023
Maintains: Market Perform
Price Target: $107 → $93
Current: $65.51
Upside: +41.96%